FISIOPATOLOGÍA DE LA ENFERMEDAD RENAL DIABÉTICA
Resumen
Palabras clave
Texto completo:
PDFReferencias
Shahbazian H, Rezaii I. Diabetic kidney disease: review of the current knowledge. J Renal Inj Prev 2013; 2(2): 73-80.
Van der Zijl NJ, Moors CC, Goossens GH, et al. Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms. Diabetes Obes Metab 2012; 14(7): 586-95.
Barutta F, Bruno G, Grimaldi S, et al. Inflammation in diabetic nephropathy: moving toward clinical bio- markers and targets for treatment. Endocrine 2015; 48(3):730-42.
Tagawa A,Yasuda M, Kume S, et al. Impaired podocyte autophagy exacerbates proteinuria in diabetic nephro- pathy. Diabetes 2016; 65(3):755-67.
Zhan M, Usman IM, Sun L, et al. Disruption of renal tubular mitochondrial quality control by myo-inositol oxygenase in diabetic kidney disease. J Am Soc Ne- phrol 2015; 26(6): 1304-21.
Tuttle K. Back to the future: glomerular hyperfiltration and the diabetic kidney. Diabetes 2017; 66: 14-16.
Heerspink HJ, Perkins BA, Fitchett DH, et al. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus cardiovascular and kidney effects, potential mechanisms, and clinical applications. Circu- lation 2016; 134(10):752-72.
DOI: http://dx.doi.org/10.47196/diab.v51i3.101
Copyright (c) 2018 Revista de la Sociedad Argentina de Diabetes (SAD)